Drug Type Cell therapy |
Synonyms Allogeneic antiCEA DART cell therapy Sorrento Therapeutics, Anti-CEA dimeric antigen receptor T-cell therapy Sorrento Therapeutics |
Target |
Action inhibitors |
Mechanism CEA inhibitors(Carcinoembryonic antigen inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | United States | - |





